Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
NMC to continue its efforts to improve and enhance the quality of medical education in the country
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
Subscribe To Our Newsletter & Stay Updated